Politics 7 June 2012 Green investments can overcome the paradox of thrift We need real public investment in Green projects now Print HTML Few economists will be entirely surprised that the UK is officially back in recession. We are witnessing a classic case of the "paradox of thrift" in which households, businesses, banks and now government are all retrenching simultaneously, cutting investment, shedding labour, restricting credit and storing money. Government policies have failed to unlock record levels of private sector savings which could revitalise the stagnant economy. Yet if the Prime Minister and his Cabinet colleagues offer a bold strategic vision which restores confidence in the direction and consistency of public policy on the green economy, there will be golden opportunities for investment which could jump-start growth. Investment has slumped mainly because households, businesses and banks are nervous about future demand, and have responded by forgoing more risky investment in physical capital, such as infrastructure. Instead, companies are squirreling away private saving into "risk-free" assets such as solvent sovereign bonds. As a result, annual private sector surpluses over the past few years have been at record levels, and amounted to £99bn last year, equivalent to 6 per cent of UK GDP. Desired saving has exceeded desired investment to such a degree that global real "risk-free" interest rates for the next 20 years have been pushed to zero and below. Savings are losing value by the day as pension funds and financial institutions pay real interest to (rather than receive interest from) governments; a truly perverse state of affairs given the need for productive investment. These low rates do not reflect a collapse in the underlying returns to capital, but instead reflect desperately depleted confidence. And when everyone retrenches simultaneously, fear of recession becomes a self-fulfilling prophecy, sustaining a vicious circle of low demand and low investment that affects the whole economy. The UK, like many advanced economies, needs to stimulate economic growth to reduce deficits and debt, but growth requires investment, and investment levels have slumped to record lows relative to output. The longer recovery is delayed and capital sits idle, the more skills are lost and the higher the misallocation of resources, making it harder to restore growth. Fiscal policy is generally constrained by the need to restore confidence in the sustainability of public debt and, with short-term interest rates close to zero, the effectiveness of monetary policy to stimulate growth is reaching its limits. What is needed to restore confidence is a clear strategic vision with supporting policies to guide investors. A vision to build an innovative, resource-efficient market economy which restores energy security, tackles climate change, and saves consumers and businesses costs in the long run. Standard macroeconomics tells us that the best time to support low-carbon investment is during a protracted economic slowdown. Resource costs are low and the potential to crowd out alternative investment and employment is small. In addition, although public budgets are stretched, there is no shortage either of private capital available for investment, or of investment opportunities with potential for profitable returns. The current opportunity should not be missed. This is about more than correcting market failures, such as those associated with greenhouse gas emissions; it is about restoring confidence through mission-driven investment which spurs innovation in a way comparable to, but bigger in scale than, the space race or the struggle to defeat cancer. Policies to encourage low-carbon investment would provide new business opportunities, generate income for investors and would have credibility in the long term because they address growing global resource challenges, while tapping into a fast-growing global market for resource-efficient activities. The most recent figures published by the Department for Business, Innovation and Skills show that the UK low-carbon and environmental goods and services sector had sales of £122.2bn in 2010-11, growing 4.7 per cent from the previous year and placing us sixth in the global league table. But the private sector is not investing as heavily as it could in green innovation and infrastructure because of a lack of confidence in future returns in this policy-driven sector. The Government should incentivise such investment by itself taking on elements of this policy risk which it "controls". By backing its own low-carbon policies, the Government can stimulate additional net private sector investment, and thereby make a significant contribution to economic growth and employment. The Government can do this, for instance, by allowing the Green Investment Bank to operate as a lending institution, offering loans to private companies so that it shares some of the risk of private investments in green infrastructure. But it also needs the Prime Minister and his Cabinet colleagues to be publicly supportive of the green economy. Whenever the Chancellor conveys the false impression that we have to make a choice between environmental responsibility and economic growth, he undermines the confidence of private sector investments. The Prime Minister helped to repair some of his damage with a speech this week that highlighted the importance of clean energy, but there needs to be a clear vision for "the greenest government ever". In past global recessions, rearmament, electrification and space races have helped restore investor confidence – this time the vision should be green. The green sector is one of the few vibrant parts of our economy at the moment. It offers a golden chance to generate growth, as long as the Government makes stronger efforts to restore private sector confidence in public policy. › Full transcript: Ed Miliband's speech on Englishness Savings and investment: A bank vault in the US. Photograph: Getty Images Dimitri Zenghelis was formerly Head of Economic Forecasting at HM Treasury and is currently a senior visiting fellow at the Grantham Research Institute on Climate Change and the Environment at London School of Economics and an adviser to Cisco systems. His paper, A strategy for restoring confidence and economic growth through green investment and innovation is available at http://www.lse.ac.uk/grantham/. More Related articles No, John McDonnell, people earning over £42,000 have not been "hit hard" by the Conservatives Cut tax and spend: what will Trumponomics mean for the global economy? It’s NOT the economy, stupid: busting the myth of how Donald Trump won Subscription offer 12 issues for £12 + FREE book LEARN MORE Close This week’s magazine
Show Hide image Sponsored byInvest Edinburgh Science & Tech 21 November 2016 Welcome to the revolution … of digital healthcare Print HTML For centuries, Edinburgh has been at the forefront of medical innovation: from the development of the hypodermic syringe (1853); insulin (1922); penicillin (1928); the Hepatitis B vaccine (1978); the MRI scanner (1980) to advanced prosthetic hands and fingers (2009). That reputation has given rise to the image of Edinburgh as an 'Ideopolis' – a sustainable knowledge-intensive city that continues to blend a strong research community with university teaching, world-renowned life sciences and a thriving tech cluster. The result is a city at the heart of today’s global revolution in digital healthcare. Thanks to a collaborative ecosystem between public and private sectors, as well as academia, Edinburgh has already introduced a number of telehealth improvements using existing technology to improve access to health services for vulnerable members of the community. “One such project involves the introduction of Home Health Monitoring in a sheltered housing complex, which will support residents with long-term conditions such as hypertension, chronic obstructive pulmonary disease, chronic heart failure and diabetes,” explains Heather Laing, Technology Enabled Care Lead with City of Edinburgh Council. “Patients are able to take regular recordings, which are sent to their local GP, enabling doctors to monitor patient health from a distance. It enables residents to self-monitor, which in turn, reduces trips to GP surgeries and unscheduled hospital admissions.” Efficient and convenient healthcare A growing, ageing global population will have a profound impact on health spending across the world. Estimated at $7.5 trillion last year, it is predicted to rise to $9.3 trillion by 2018. This huge challenge is central to why technology is increasingly blurring the boundaries between the physical, biological and digital worlds. And nowhere is this trend more evident than in wearable technology. San Diego-headquartered continuous glucose monitoring (CGM) market leader, Dexcom, has recently expanded into Europe with the opening of a new product support and research and development office in Edinburgh. For people living with diabetes who require intensive insulin therapy, advances in CGM are delivering life-changing improvements to their insulin control regimes. Dexcom’s passive CGM devices are worn on the skin, 24-hours a day, delivering real time information on glucose levels and providing users with alarms if glucose levels exceed pre-defined limits. Diabetes costs the NHS in England and Wales more than £1.5m every hour, or nearly 10% of the total NHS budget. “Diabetes is one of the leading causes of morbidity, mortality and cost in today’s healthcare sector, which is why it’s such an important topic,” explains John Lister, General Manager, Europe, Middle East & Africa. In terms of clinical benefit, dozens of studies have been published that demonstrate the benefits of CGM; one of the reasons why Dexcom is collaborating with Google Verily to develop the next generation of miniaturised and inexpensive CGM sensors. There’s also the convenience of being able to wear a sensor and check blood glucose levels on a smartphone, enabling parents and carers of those with diabetes, to monitor blood glucose remotely. With the patient monitoring market estimated to be worth $35 billion globally, considerable opportunities exist for technology businesses to make their mark. Companies such as Edinburgh start-up snap40 are already capitalising. In what is thought to be the largest ever seed round by a Scotland-based start-up, it has just secured £2m in seed funding through Par Equity for its wearable, health-monitoring armband. snap40’s technology enables hospitals and GP practices to monitor a whole host of patient vital signs, enabling the early detection of major health risks. Big data, bigger impact Technology also aims to personalise medicine in order to provide each patient with their own treatment plan – that is, to tailor treatments to individual patients based on their genetic makeup. It’s in this respect that Scotland is fortunate to have some of the best data in the world. Few other countries offer researchers the opportunity to work with high quality, consistent data at a national level. Supported by Scotland-wide initiatives such as The Data Lab, as well as regional infrastructure such as the Edinburgh BioQuarter, new collaborations between industry, public sector and universities are paving the way for commercially viable ground-breaking innovations. “Medicine and medical expertise remains key. Technology allows us to articulate that expertise in new ways,” explains Professor David Robertson, Co-head of the Medical Centre for Informatics, part of the Usher Institute of Population Health Sciences and Informatics.” “If you consider the impact of the telescope on astronomy, then we’re potentially looking at a similar seismic shift in our ability to understand the human body and revolutionise the efficacy of treatments.” Professor David Robertson. Professor Robertson continues: “To have statistically relevant medical studies, you need bigger populations, because you’re looking for a very precise set of characteristics that define a small section of the wider population. That means you’re driven to collecting data on a very large scale – something that we’re focused on at the Usher Institute.” Collaboration is key, with multidisciplinary teams combining excellence in data science, clinical practice and large-scale public health systems, such as those employed by NHS Scotland. “That’s what we have at the Edinburgh BioQuarter, both at the Usher Institute and the Scottish hub of the Farr Institute, which works at a UK level,” adds Professor Robertson. What’s more, for medical informatics to fulfil its potential, data intensive healthcare requires the commercialisation of ideas, systems and products – precisely the type of environment found within the Edinburgh BioQuarter. “While innovations are driven by medical need, the sheer scale of the data science challenge is immense. To make real progress in this field, you need all three working collaboratively. There aren’t many places in the world where that sort of culture is being nurtured; where innovation goes way beyond developing new sensor technologies to look at the population level.” Decoding the data One enterprise already having a commercial impact in data intensive healthcare is Edinburgh-based Aridhia. As a key partner in the creation of the Stratified Medicine Scotland Innovation Centre (SMS-IC), Aridhia’s data science platform, AnalytiXagility, underpins the centre’s work. This vital collaboration tool is able to capture and integrate research studies, trials and clinical care data, combining workflows and enabling data sharing across widespread teams. The result is a system that helps to unlock the potential of precision medicine research, accelerating the commercialisation of the resulting assets and expertise. “Society is so digitally driven now that from the moment that a patient steps into their doctor’s surgery, they expect their healthcare to be as personalised as their internet shopping, banking or travel experience. But that’s not how it currently works,” says Rodrigo Barnes, Chief Technology Officer. “As people move from being passive recipients to active, informed consumers in all other walks of life, there is a need to deliver a personalised experience to patients that allows them to become active participants in their own care.” “We’re certainly at the dawn of a new era in digital healthcare,” summarises Professor Robertson. “It’s a race however. There are many transformational, possibly revolutionary, discoveries to be made at this current junction between medicine and informatics.” The rewards are likely to be significant for successful researchers and businesses, but ultimately, this revolution has the potential to benefit all of mankind. For further information www.investinedinburgh.com More Related articles #TrumpsComingChallenge: Destroying demagogues in the digital age A terminally ill teenager is being preserved in hope of a future cure – what happens next? Did fake news on Facebook swing the US election?